Comparison of antiviral compounds against human herpesvirus 6 and 7

Antiviral Research

Volumn 40, Issue 1-2, 1998, Pages 73-84

  Yoshida, Mariko ^a,b   Yamada, Masao ^a   Tsukazaki, Takashi ^a   Chatterjee, Subhendra ^b   Lakeman, Fred D ^b   Nii, Shiro ^a   Whitley, Richard J ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UAB   (United States)

Author keywords

Antiviral compounds; Benzimidazole ribonucleosides; Dot blot method; Human herpesvirus 6; Human herpesvirus 7; Virus replication

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; FOSCARNET; GANCICLOVIR; PENCICLOVIR; PHOSPHONIC ACID DERIVATIVE; PYROPHOSPHORIC ACID DERIVATIVE; RIBONUCLEOSIDE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HERPES; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; DIPHOSPHATES; GUANINE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; PHOSPHONIC ACIDS; RIBONUCLEOSIDES; VIRUS REPLICATION;

EID: 0032402266     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(98)00049-7     Document Type: Article

References (60)

1. Ablashi D.V., Balachandran N., Josephs S.F., Hung C.L., Krueger G.R., Kramarsky B., Salahuddin S.Z., Gallo R.C. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology. 184:1991;545-552.
2. Agut H., Collandre H., Aubin J.T., Gúetard D., Favier V., Ingrand D., Montagnier L., Huraux J.M. In vitro sensitivity of human herpesvirus-6 to antiviral drugs. Res. Virol. 140:1989;219-228.
3. Åkesson-Johansson et al., 1990.
4. Åkesson-Johansson A., Harmenberg J., Wahren B., Linde A. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob. Agents Chemother. 34:1990;2417-2419.
5. Asano Y., Yoshikawa T., Suga S., Yazaki T., Kondo K., Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet. 335:1990;862-863.
6. Asano Y., Yoshikawa T., Suga S., Nakashima T., Yazaki T., Fukuda M., Kojima S., Matsuyama T. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. New Engl. J. Med. 324:1991;634-635.
7. Aubin J.-T., Collandre H., Candotti D., Ingrand D., Rouzioux C., Burgard M., Richard S., Huraux J.M., Agut H. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J. Clin. Microbiol. 29:1991;367-372.
8. Black J.B., Inoue N., Kite-Powell K., Zaki S., Pellet P.E. Frequent isolation of human herpesvirus 7 from saliva. Virus Res. 29:1993;91-98.
9. Black J.B., Burns D.A., Goldsmith C.S., Feorino P.M., Kite-Powell K., Schinazi R.F., Krug P.W., Pellet P.E. Biologic properties of human herpesvirus 7 strain SB. Virus Res. 52:1997;25-41.
10. Burns W.H., Sandford G.R. Susceptibility of human herpesvirus 6 to antivirals in vitro. J. Infect. Dis. 162:1990;634-637.
11. Challoner P.B., Smith K.T., Parker J.D., MacLeod D.L., Coulter S.N., Rose T.M., Schultz E.R., Bennett J.L., Garber R.L., Chang M., Schad P.A., Stewart P.M., Nowinski R.C., Brown J.P., Burmer G.C. Plaque associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;7440-7444.
12. Crumpacker C.S. Mechanism of action of foscarnet against viral polymerases. Am. J. Med. 92:1992;3S-7S.
13. Crumpacker C.S. Ganciclovir. New Engl. J. Med. 335:1996;721-729.
14. De Clercq E. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. Adv. Virus Res. 42:1993;1-55.
15. Downing R.G., Sewankambo N., Serwadda D., Honess R., Crawford D., Jarrett R., Griffin B.E. Isolation of human lymphotropic herpesviruses from Uganda. Lancet. 2(8555):1987;390.
16. Faulds D., Heel R.C. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 39:1990;597-638.
17. Fields R.D., Lancaster M.V. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am. Biotechnol. Lab. 11(4):1993;48-50.
18. Frenkel, N., Roffman, E., 1996. Human herpesvirus 7. In: Field, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B., Straus, S.E., (Eds.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp. 2609-2622.
19. Frenkel N., Schirmer E.C., Wyatt L.S., Katsafanas G., Roffman E., Danovich R.M., June C.H. Isolation of a new herpesvirus from human CD4+ T cells. Proc. Natl. Acad. Sci. USA. 87:1990;748-752.
20. Gompels U.A., Nicholas J., Lawrence G., Jones M., Thomson B.J., Martin M.E., Efstathiou S., Craxton M., Macaulay H.A. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology. 209:1995;29-51.
21. Hirsch, M.S., Kaplan, J.C., D'Aquila, R.T., 1996. Antiviral agents. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B., Straus, S.E. (Eds.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp. 431-466.
22. Ho H.T., Woods K.L., Bronson J.J., De Boeck H., Martin J.C., Hitchcock M.J.M. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41:1992;197-202.
23. Inoue N., Dambaugh T.R., Pellet P.E. Molecular biology of human herpesviruses 6A and 6B. Infect. Agents Dis. 2:1993;343-360.
24. Isomura H., Yamada M., Yoshida M., Tanaka H., Kitamura T., Oda M., Nii S., Seino Y. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J. Med. Virol. 52:1997;406-412.
25. Kim U.C., Misco P.F., Luh B.Y., Hitchcock M.J.M., Ghazzouli I., Martin J.C. A new class of acyclic phosphonate nucleotide analogues: phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents. J. Med. Chem. 34:1991;2286-2294.
26. Knox K.K., Pietryga D., Harrington D.J., Franciosi R., Carrigan D.R. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin. Infect. Dis. 20:1995;406-413.
27. Kondo K., Nagafuji H., Hata A., Tomomori C., Yamanishi K. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J. Infect. Dis. 167:1993;1197-1200.
28. Littler E., Stuart A.D., Chee M.S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature. 358:1992;160-162.
29. Lopez C., Pellet P., Stewart J., Goldsmith C., Sanderlin K., Black J., Warfield D., Feorino P.M. Characteristics of human herpesvirus-6. J. Infect. Dis. 157:1988;1271-1273.
30. Lurain N.S., Spafford L.E., Thompson K.D. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J. Virol. 68:1994;4427-4431.
31. McCullers J.A., Lakeman F.D., Whitley R.J. Human herpesvirus 6 is associated with focal encephalitis. Clin. Infect. Dis. 21:1995;571-576.
32. Metzger C., Michel D., Schneider K., Luske A., Schlicht H.J., Mertens T. Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus. J. Virol. 68:1994;8423-8427.
33. Nassiri M.R., Emerson S.G., Devivar R.V., Townsend L.B., Drach J.C., Taichman R.S. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells. Br. J. Haematol. 93:1996;273-279.
34. Neyts J., Snoeck R., Schols D., Balazarini J., De Clercq E. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-1,3-hydroxy-2-propoxymethyl)-guanine (DHPG). Virology. 179:1990;41-50.
35. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol. 70:1996;5975-5989.
36. Okuno T., Higashi K., Shiraki K., Yamanishi K., Takahashi M., Kokado Y., Ishibashi M., Takahara S., Sonoda T., Tanaka K., Baba K., Yabuuchi H., Kurata T. Human herpesvirus 6 infection in renal transplantation. Transplantation. 49:1990;519-522.
37. Pellet, P.E., Black, J.B., 1996. Human herpesvirus 6. In: Field, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B., Struas, S.E. (Eds.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp. 2587-2608.
38. Pietroboni G.R., Harnett G.B., Bucens M.R. Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro. J. Virol. Methods. 24:1989;85-90.
39. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
40. Reymen D., Naesens L., Balzarini J., Holy A., Dvorakova H., De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res. 28:1995;343-357.
41. Salahuddin S.Z., Ablashi D.V., Markham P., Joseph S.F., Sturzemegger S., Kaplan M., Halligan G., Biberfield P., Wong-Staal F., Kramarsky B., Gallo R.C. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 234:1986;596-601.
42. Saluja S., Zou R., Drach J.C., Townsend L.B. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy)methyl]- and -1-[(1,3-dihydroxy-2-propoxy)methyl] benzimidazoles. J. Med. Chem. 39:1996;881-891.
43. Snoeck R., Sakuma T., De Clercq E., Rosenberg I., Holy A. (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob. Agents Chemother. 32:1988;1839-1844.
44. Streicher H.Z., Hung C.L., Ablashi D.V., Hellman K., Saxinger C., Fullen J., Salahuddin S.Z. In vitro inhibition of human herpesvirus-6 by phosphonoformate. J. Virol. Methods. 21:1988;301-304.
45. Sullivan V., Biron K.K., Talarico C., Stant S.C., Davish M., Pozzi L.M., Coen D.M. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob. Agents Chemother. 37:1993;19-25.
46. Takahashi K., Suzuki M., Iwata Y., Shigeta S., Yamanishi K., De Clercq E. Selective activity of various nucleoside and nucleotide analogues against human herpesvirus 6 and 7. Antiviral Chem. Chemother. 8(1):1997;24-31.
47. Takahashi Y., Yamada M., Nakamura J., Tsukazaki T., Padilla J., Kitamura T., Yoshida M., Nii S. Transmission of human herpesvirus 7 through multi-generational families in the same household. Pediatr. Infect. Dis. J. 16:1997;975-978.
48. Tanaka K., Kondo T., Torigoe S., Okada S., Mukai T., Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthema subitum). J. Pediatr. 125:1994;1-5.
49. Torigoe S., Koide W., Yamada M., Miyashiro E., Tanaka-Taya K., Yamanishi K. Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediatr. 129:1996;301-305.
50. Torigoe S., Tabata N., Yamada M., Koide W., Ihara T. Prolonged viremia and immune response to human herpesvirus 7 in an infant with liver dysfunction. Pediatrics. 100:1997;398-400.
51. Townsend L.B., Devivar R.V., Turk S.R., Nassiri M.R., Drach J.C. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 38:1995;4098-4105.
52. Tsukazaki, T., Yoshida, M., Namba, H., Yamada, M., Shimizu, Y., Nii, S., 1998. Development of a dot-blot neutralizing assay for HHV-6 and -7 using specific monoclonal antibodies. J. Virol. Methods 73, 141-149.
53. Vere Hodge R.A., Cheng Y.C. The mode of action of penciclovir. Antiviral Chem. Chemother. 4:1993;13-24.
54. Wagstaff A.J., Faulds D., Goa K.L. Acyclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 47:1994;153-205.
55. Whitley R.J., Gnann J.W. Acyclovir: a decade later. New Engl. J. Med. 327:1992;782-789.
56. Williams, M.V., 1992. HHV-6: response to antiviral agents. In: Ablashi, D.V., Krueger, G.R.F., Salahuddin, S.Z. (Eds.), Human Herpesvirus-6. Elsevier Science, Amsterdam, pp. 317-335.
57. Wyatt L.S., Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J. Virol. 66:1992;3206-3209.
58. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthema subitum. Lancet. 1:1988;1065-1067.
59. Yoshida M., Yamada M., Chatterjee S., Lakeman F., Nii S., Whitley R.J. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J. Virol. Methods. 58:1996;137-143.
60. Zimmermann A., Michel D., Pavic I., Hampl W., Lüske A., Neyts J., De Clercq E., Mertens T. Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses. Antiviral Res. 36:1997;35-42.